Key result
The development of 'regenerative pharmacology' aims to optimize cell-based therapies for myocardial repair by targeting pharmacological interactions that control stem cell survival, homing, and paracrine effects.
Understanding the pharmacological interactions between standard cardiovascular medications and regenerative cell therapies is crucial for the successful clinical translation of cardiac repair strategies.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Choudhury et al. (2013) conducted a review in Cardiovascular disease / Myocardial infarction. Regenerative pharmacology and stem cell therapy was evaluated. The development of 'regenerative pharmacology' aims to optimize cell-based therapies for myocardial repair by targeting pharmacological interactions that control stem cell survival, homing, and paracrine effects.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: